Lg Life Sciences, Limited

Lg Chem, Ltd

Heui Sul Park

Tae Hun Kim

Hyoung Jin Kim

Soon Ha Kim

Hyo Shin Kwak

Sung Bae Lee

Sun Young Koo

Seung Hyun Yoon

Eok Park

Dong Ook Seo

Seung Yup Paek

Chul Woong Chung

Vasily Artemov

Ji Hyun Kim

Ju Young Kim

Sung Pil Choi

Eun Sil Choi

Sung Ho Kim

Hyo Kyun Chung

Min Ho Shong

Deok Seong Park

Geun Tae Kim

Ki Chul Koo

Wan Su Park

Kwang Min Park

Hyo Soo Kim

Hyun Jai Cho

Mi Kyoung Cho

Seon Yeong Gu

Du Hee Park

Kyoung Hee Kim

Jin Gu Park

Seo Hyun Ahn

Cheol Kyu Jung

Jeong Uk Song

The present application relates to an indole compound represented by formula (1): a pharmaceutically acceptable salt or isomer thereof, a composition for prevention or treatment of necrosis and necrosis-associated diseases, and a method for preparing the composition, the composition comprising the indole compound or the pharmaceutically acceptable salt or isomer thereof as an active ingredient.

Indole compound as inhibitor of necrosis

The present invention relates to a pharmaceutical composition comprising a compound of formula (1), (2) or (3) as defined in the specification for the prevention or treatment of diseases associated with oxidative stress, mitochondria dysfunction, hypoxic injury, necrosis and/or ischemic reperfusion injury, and a cosmetic composition comprising an indole compound having an antioxidant effect.

Pharmaceutical composition comprising indole compound

The present invention relates to an indole amide compound represented by formula (1), a pharmaceutically acceptable salt or isomer thereof, a composition for prevention or treatment of necrosis and necrosis-associated diseases, and a method for preparing the composition, the composition comprising the indole compound or the pharmaceutically acceptable salt or isomer thereof as an active ingredient.

Indole amide compound as inhibitor of necrosis

The present invention relates to a pharmaceutical composition for preventing or treating fatty liver diseases, containing (tetrahydropyran-4-yl)-[2-phenyl-5-(1,1-dioxo-thiomorpholin-4-yl)methyl-1H-indol-7-yl]amine or a pharmaceutically acceptable salt thereof as active ingredients. (Tetrahydropyran-4-yl)-[2-phenyl-5-(1,1-dioxo-thiomorpholin-4-yl)methyl-1H-indol-7-yl]amine or a pharmaceutically acceptable salt thereof, according to the present invention, can effectively inhibit fatty liver, hepatitis and hepatic fibrosis and can be useful for preventing or treating NAFLD, and in particular, NASH.

Composition for preventing or treating fatty liver diseases

The present invention relates to indole or indazole compounds, pharmaceutically acceptable salts or isomers thereof which are useful for the prevention or treatment of cellular necrosis and necrosis-associated diseases. The present invention also relates to a method and a composition for the prevention or treatment of cellular necrosis and necrosis-associated diseases, comprising said indole or indazole compounds as an active ingredient.

Indole and indazole compounds as an inhibitor of cellular necrosis

The present invention relates to new indole compounds, pharmaceutically acceptable salts or isomers thereof which are useful for the prevention or treatment of cellular necrosis and necrosis-associated diseases. The present invention also relates to a method and a composition for the prevention or treatment of cellular necrosis and necrosis-associated diseases, comprising said indole compounds as an active ingredient.

Indole compounds as an inhibitor of cellular necrosis

The present invention relates to novel compounds which are effective as an inhibitor for xanthine oxidase, a process for preparing the same, and a pharmaceutical composition comprising a therapeutically effective amount of the same.

Compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same

The present invention relates to a composition for preserving cells, tissues and organs, comprising as an active ingredient indole and indazole compounds of formula (1), or a pharmaceutically acceptable salt or isomer thereof, which are effective for preventing injury of organs, isolated cell systems or tissues caused by cold storage, transplant operation or post-transplantation reperfusion; a preservation method; and a preparation method of the composition.

Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect

Disclosed are new compounds of formula (1) exhibiting excellent activity for glucokinase, pharmaceutical compositions having the same as an active ingredient, and a method of using the same as an active ingredient for lowering blood glucose level: in which the substituents are as defined herein.

Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient

Growing community of inventors

Daejeon, South Korea

Heui Sul Park